FTC-SUD: A Substance Use Adaptation of Fathering Through Change

Sponsor
University of Oregon (Other)
Overall Status
Completed
CT.gov ID
NCT04532619
Collaborator
(none)
41
1
2
18
2.3

Study Details

Study Description

Brief Summary

This study is a randomized control trial of the Fathering Through Change intervention, delivered via text messaging, to fathers in recovery for substance use disorders.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Fathering Through Change
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
41 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Pilot Study of the Fathering Through Change Intervention for Fathers With Substance Use Disorders
Actual Study Start Date :
Jul 1, 2020
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

6 weeks of Fathering Through Change videos and 3 individual coaching calls.

Behavioral: Fathering Through Change
Fathering Through Change is an adaptation of Parent Management Training Oregon. This pilot provides a limited version of Fathering Through Change via text messaged and emailed weekly video content and includes individual coaching calls.

No Intervention: Control

Links to parenting websites

Outcome Measures

Primary Outcome Measures

  1. Group mean change at 6 weeks and 4 months on parenting self-efficacy on the Tool of Parenting Self-Efficacy [baseline to 6 weeks and baseline to 4 months]

    TOPSE consists of 48 self-efficacy statements that address six domains of parenting; emotion and affection, play and enjoyment, empathy and understanding, control, discipline and boundary setting, pressures of parenting, self-acceptance, and learning and knowledge. There are six self-efficacy statements for each domain and parents indicate how much they agree with each statement by responding to a Likert scale from 0-10 where 0 equates to completely disagree and 10 equates to completely agree. A higher overall score indicates greater self-efficacy.

  2. Group mean change at 6 weeks and 4 months on parenting skills on the Parenting Practices Interview [baseline to 6 weeks and baseline to 4 months]

    Parenting Practices Interview is a standardized instrument to measure parenting skills. It includes three subscales: harsh discipline, inept discipline, and positive parenting. It includes 35 items on all rated on a 7-point scale. Higher scores in each subscale indicate greater frequency of the behavior.

Secondary Outcome Measures

  1. Group mean change at 6 weeks and 4 months on substance use [baseline to 6 weeks and baseline to 4 months]

    Substance use is collected using the Center on Parenting and Opioids substance use questionnaire. We will measure substance use as a both a dichotomous variable (using or not using) and as frequency of use of alcohol, cannabis, and illicit substances in the past thirty days.

  2. Group mean change at 4 months on child behavior [baseline to 4 months]

    Child behavior as measured by the Strengths and Difficulties Questionnaire prosocial behavior scale. This scale includes five items, rated on a 3-point scale ranging from 0 to 2. Higher scores indicate greater prosocial behavior.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • identify as being in recovery

  • abstinent from illicit substances for at least 1 day and less than one year at time of enrollment

  • parenting responsibilities for a child between the ages of 3-16

  • spend at least 2 hours per week with child between ages of 3-16

  • English speaking

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Willamette Family Treatment Center Eugene Oregon United States 97402

Sponsors and Collaborators

  • University of Oregon

Investigators

  • Study Director: Camille C Cioffi, PhD, University of Oregon

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
University of Oregon
ClinicalTrials.gov Identifier:
NCT04532619
Other Study ID Numbers:
  • 12132019.029
First Posted:
Aug 31, 2020
Last Update Posted:
Mar 25, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2022